Publication | Open Access
Gemcitabine plus epirubicin in patients with advanced urothelial carcinoma who are not eligible for platinum‐based regimens
36
Citations
27
References
2002
Year
At the doses given in this study, gemcitabine and epirubicin had a good tolerability profile with interesting activity in patients with advanced urothelial carcinoma who were not fit for cisplatin-based regimens.
| Year | Citations | |
|---|---|---|
Page 1
Page 1